You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Details for New Drug Application (NDA): 018664

✉ Email this page to a colleague

« Back to Dashboard

NDA 018664 describes IOSAT, which is a drug marketed by Anbex and is included in one NDA. It is available from one supplier. Additional details are available on the IOSAT profile page.

The generic ingredient in IOSAT is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
Summary for 018664
Ingredient:potassium iodide
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018664
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IOSAT potassium iodide TABLET;ORAL 018664 NDA Anbex Inc. 51803-001 51803-001-01 14 TABLET in 1 PACKAGE (51803-001-01)
IOSAT potassium iodide TABLET;ORAL 018664 NDA Anbex Inc. 51803-001 51803-001-10 10 PACKAGE in 1 BAG (51803-001-10) / 14 TABLET in 1 PACKAGE (51803-001-01)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength130MG
Approval Date:Oct 14, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength65MG
Approval Date:May 12, 2011TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.